177 related articles for article (PubMed ID: 8833765)
21. Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Abe K; Taguchi K; Wasai T; Ren J; Utsunomiya I; Shinohara T; Miyatake T; Sano T
Brain Res; 2001 Jul; 907(1-2):134-8. PubMed ID: 11430895
[TBL] [Abstract][Full Text] [Related]
22. Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson's disease.
Naoi M; Maruyama W; Akao Y; Yi H
Neurotoxicol Teratol; 2002; 24(5):579-91. PubMed ID: 12200189
[TBL] [Abstract][Full Text] [Related]
23. Effect of 1,2,3,4,-tetrahydroisoquinoline administration under conditions of CYP2D inhibition on dopamine metabolism, level of tyrosine hydroxylase protein and the binding of [3H]GBR 12,935 to dopamine transporter in the rat nigrostriatal, dopaminergic system.
Lorenc-Koci E; Antkiewicz-Michaluk L; Wardas J; Zapała M; Wierońska J
Brain Res; 2004 May; 1009(1-2):67-81. PubMed ID: 15120584
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action of salsolinol on tyrosine hydroxylase.
Briggs GD; Nagy GM; Dickson PW
Neurochem Int; 2013 Dec; 63(8):726-31. PubMed ID: 24083987
[TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity of an endogenous brain amine, 1-benzyl-1,2,3,4-tetrahydroisoquinoline, in organotypic slice co-culture of mesencephalon and striatum.
Kotake Y; Ohta S; Kanazawa I; Sakurai M
Neuroscience; 2003; 117(1):63-70. PubMed ID: 12605893
[TBL] [Abstract][Full Text] [Related]
26. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
27. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
Yoshida M; Ogawa M; Suzuki K; Nagatsu T
Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
[TBL] [Abstract][Full Text] [Related]
28. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X
J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659
[TBL] [Abstract][Full Text] [Related]
29. Cell death of dopamine neurons in aging and Parkinson's disease.
Naoi M; Maruyama W
Mech Ageing Dev; 1999 Nov; 111(2-3):175-88. PubMed ID: 10656535
[TBL] [Abstract][Full Text] [Related]
30. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
[TBL] [Abstract][Full Text] [Related]
31. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
Maruyama W; Strolin-Benedetti M; Naoi M
Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
[TBL] [Abstract][Full Text] [Related]
32. A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains.
Naoi M; Maruyama W; Matsubara K; Hashizume Y
Neurosci Lett; 1997 Oct; 235(1-2):81-4. PubMed ID: 9389601
[TBL] [Abstract][Full Text] [Related]
33. Experimental change on dopaminergic neurons in striatum of Parkinson disease rats.
Chen XY; Li J; Qi WQ; Shen SH
Histol Histopathol; 2007 Oct; 22(10):1085-90. PubMed ID: 17616935
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Wąsik A; Romańska I; Michaluk J; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
Neurotox Res; 2016 Apr; 29(3):351-63. PubMed ID: 26303030
[TBL] [Abstract][Full Text] [Related]
35. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
Naoi M; Maruyama W
Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
[No Abstract] [Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
37. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.
Kotake Y; Tasaki Y; Makino Y; Ohta S; Hirobe M
J Neurochem; 1995 Dec; 65(6):2633-8. PubMed ID: 7595560
[TBL] [Abstract][Full Text] [Related]
38. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
39. Type B monoamine oxidase and neurotoxins.
Naoi M; Maruyama W
Eur Neurol; 1993; 33 Suppl 1():31-7. PubMed ID: 8375430
[TBL] [Abstract][Full Text] [Related]
40. [Biochemical changes in striatum of Parkinson's disease rat model observed by modified proton magnetic resonance spectroscopy].
Zheng Z; Fu W; Wang J; Sun X; Zhuang W; Lu E; Yang L; Lu C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):524-8. PubMed ID: 20649011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
